Related Experiment Videos
Apoptotic markers in cancer
1Institute of Clinical Chemistry, University Hospital Munich-Grosshadern, D-81377 Munich, Germany.
Clinical Biochemistry
|July 6, 2004
Summary
Cancer cell death and proliferation influence disease progression and treatment response. Circulating apoptotic markers offer a non-invasive method to monitor cancer treatment and predict patient outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Apoptotic processes are crucial in cancer development and response to therapy.
- Changes in cancer cell death and proliferation impact disease progression.
- Circulating apoptotic products can be measured non-invasively.
Purpose of the Study:
- To review the features of apoptotic and necrotic cell death in cancer.
- To summarize intracellular pathways mediating apoptosis.
- To discuss the utility of circulating apoptotic markers in cancer management.
Main Methods:
- Literature review of apoptosis and cancer.
- Summary of intracellular apoptotic pathways.
- Analysis of circulating apoptotic markers in cancer patients.
Main Results:
- The balance between cell death and proliferation is key in malignancy.
- Circulating apoptotic products aid in assessing disease extent and aggressiveness.
- Serial measurement of these markers can monitor treatment and predict response.
Conclusions:
- Apoptotic and necrotic cell death dynamics are vital in cancer.
- Circulating apoptotic markers have significant diagnostic, prognostic, and predictive value.
- Monitoring these markers facilitates personalized cancer treatment strategies.